Register now for the Florida Society of Pathologists 45th Annual Pathology Conference, February 22-24, 2019 at Disney's Contemporary Resort in Orlando, Florida. The Annual Conference will feature innovative topics in pathology including the interactive microscopy course, featuring case presentations related to topics featured throughout the conference.
In addition to the educational offerings, attendees will have an opportunity to connect with colleagues and interact with industry leaders in the field of pathology during exhibit hall social functions.
Official Program of the 45th Annual Pathology Conference
|Abstract Poster Submission #1|
|Disclosure of Funding Support|
|Choose one of the following Topics|
Mahul B. Amin, MD
Gerwin Endowed Professor and Chairman
Department of Pathology and Lab Medicine
University of Tennessee Health Sciences Center
Rebekah Bernard, MD
Gulf Coast Direct Primary Care
Fort Myers, FL
Steven D. Billings, MD
Professor of Pathology
Cleveland Clinic Lerner College of Medicine
Marilyn Bui, MD, PhD
Scientific Director of Analytic Microscopy Core
Section Head of Bone and Soft Tissue Pathology
Director of Cytopathology Fellowship and President of Medical Staff
Moffitt Cancer Center
Eric F. Glassy, MD, FCAP
Affiliated Pathologists Medical Group
Rancho Dominguez, CA
Carmen Gomez-Fernandez, MD, FASCP, FCAP
Professor of Pathology, Vice Chair of Education
Director of Breast and ENT Pathology Services
Professor of Clinical Pathology
University of Miami Miller School of Medicine
Oleksandr N. Kryvenko, MD
Associate Professor of Pathology and Urology
Director of Genitourinary Pathology Fellowship
University of Miami Health System
Ana Maria Medina, MD
Department of Pathology and Laboratory Medicine,
Mount Sinai Medical Center
Florida International University Herbert Wertheim College of Medicine
Miami Beach, FL
Alan E. Siroy, MD, MPH
Clinical Assistant Professor
Department of Pathology, Immunology, and Laboratory Medicine
University of Florida College of Medicine
Disney's Contemporary Resort
4600 North World Drive
Lake Buena Vista, FL 32830
Disney is rolling out the red carpet! Visit this website built exclusively for attendees of the 45th Annual Pathology Conference, where you can take advantage of special ticket options to Disney parks. Don't miss out on this great feature!
Rooms at the Disney’s Contemporary Resort and Disney’s Grand Floridian Resort & Spa are SOLD OUT on Thursday, February 21 and Friday, February 22.
There are several resorts that Walt Disney World partners with that are located in Disney Springs that currently have availability. A few recommendations are Hilton Orlando Lake Buena Vista, Wyndham Lake Buena Vista and Holiday Inn Orlando – Disney Springs Area .
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Florida Medical Association and the Florida Society of Pathologists. The Florida Medical Association is accredited by the ACCME to provide continuing medical education for physicians.
The Florida Medical Association designates this live activity for a maximum of 13.0 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CRITERIA FOR SUCCESS
Statements of credit/participation will be awarded based on the participant’s attendance at each session and submission of the activity evaluation form. A statement of credit will be available upon completion of an online evaluation/claimed credit form at www.flpath.org/claimcme. If you have questions about this CME/CE activity, please contact the FSP at 904-309-6261. Credit must be claimed by March 1, 2019.
This activity is designed to meet the needs of practicing physicians, pathologists, and other specialists involved with anatomic pathology.
STATEMENT OF NEED
The field of pathology is constantly changing, and many of the most important advances in the field. In the setting of new technology, techniques and advancements in the field, practice gaps are inevitable. As such, pathologists require ongoing educational opportunities to stay current in order to maintain and improve their knowledge and competence in the field.
At the conclusion of this activity, all participants should be able to:
This activity is supported by an educational grant from Bristol-Myers Squibb Company; Genomic Health, Inc.; Olympus Grants Committee; and Siemens Medical Solutions USA, Inc.
The planners of this activity disclosed no financial relationships relevant to the content to be presented.
The speakers for this activity disclosed no financial relationships with commercial interests whose products or services have a direct bearing on the subject matter of these presentations with the exception of Marilyn Bui, MD, PhD who has a NIH/NCI Cancer Center Support Grant as a co-investigator (5% effort), Rebekah Bernard, MD who has authored self-published books regarding physician wellness, and Eric F. Glassy, MD, FCAP who is a consultant for Leica Biosystems.
We invite you to participate as a sponsor and exhibitor in the Florida Society of Pathologists 45th Annual Pathology Conference taking place on February 22-24,2019 in Orlando,FL. Interact and showcase your products and services with approximately 300 pathologists.
For more information on exhibiting or sponsoring please call 904-309-6204 or email email@example.com
CME Lunch Symposium
Molecular Testing for EGFR Mutations in the Context of a Changing Treatment Landscape, Evolving Testing Options
New Guidelines: What Pathologists Need to Know and Do
Friday, February 22, 2019
Registration and Lunch: 11:30-11:45 am / Program: 11:45 am-12:45 pm
Sorcerer’s Ballroom 1&2
As the fields of oncology, pathology, genetics, and genomics continue to advance, molecular genetic profiling has become an integral tool for guiding the management of patients with advanced NSCLC, and pathologists are helping to lead the way into this new era of precision oncology. Learn more about the latest science and recommendations on testing for EGFR and other key driver mutations in patients with NSCLC throughout the disease continuum, new data on targeted treatments for EGFR-mutant disease, and how to implement testing guidelines into pathology practice.
Lunch will be provided.
To RSVP and save your seat for this educational program, please email firstname.lastname@example.org.
Qihui "Jim" Zhai, MD, FACP
Professor of Laboratory Medicine and Pathology
Mayo College of Medicine
Director FISH Laboratory
Mayo Clinic Florida
This CME/MOC activity is jointly provided by Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education.
This activity is supported by an independent education grant from AstraZeneca.
Innovation Lab Luncheon
Current and Emerging Biomarkers: Science, Technologies, and Practicalities
Saturday, February 23, 2019
Registration and Lunch: 12:45-1:00 pm / Program: 12:00-1:00 pm
Sorcerer’s Ballroom 1&2
The use of biomarkers in cancer treatment has allowed for increased patient segmentation. This has been enabled by advances in development of new biomarkers that allow for further characterization of the tumor microenvironment. This talk will focus on ongoing use of current and emerging biomarkers and use of composite biomarkers as pharmacodiagnostic tools that are paving the path towards precision medicine.
Lunch will be provided.
View More Information and Pre-Register
Anthony Magliocco, MD
Chair and Senior Member, Department of Anatomic Pathology
H. Lee Moffitt Cancer Center and Research Institute
This innovation lab is sponsored by Bristol-Myers Squibb.
RocheDx Talks – Product Theater Series
Attend one of these quick fire hot topic sessions sponsored by Roche Diagnostics. The presentations will be held in the exhibit hall throughout the weekend on the dates and times noted below. Each presentation is approximately 15-20 minutes long and will be repeated on demand.
Friday, February 22, 2019
3:15-4:00 pm Five Proteins, One Answer: Ventana MMR IHC Panel
6:00-7:00 pm Look Into the Light: HER-2/neu and HER2 Dual ISH
Saturday, February 23, 2019
7:30-8:00 am Scoring the PD-L1 IHC Assay in Advanced/Metastatic Urothelial Carcinoma
10:15-11:00 am Cardiac TnT (Troponin T) Gen 5 Clinical Impact and Utility
Alex Chang, PhD, Scientific Affairs Manager
Tabari Baker, PhD, Scientific Affairs Manager
Erin Marner, MD, Pathologist, Medical and Scientific Affairs
Michael Lynch, MD, Pathologist, Medical and Scientific Affairs
Angie Baker, MSN, RN, CCRN Alumnus, Regional Scientific Affairs Manager
Alexis Power, MSN, RN, CCRN Alumnus, Medical Scientific Liaison
College of American Pathologists Florida House of Delegates Reception
CAP will host a reception for Florida delegates to receive an update on delegation activities. Attendees that are interested in becoming a part of the Florida delegation are also invited to attend! Cocktails will be served.
Saturday, February 23, 2019
Fantasia Ballroom K&L
Admera Health is a CLIA certified CAP accredited laboratory, utilizing next-generation genomics technology that spans the continuum of cancer patient care. Our expertise includes pharmacogenomics (PGx) and non-invasive liquid biopsy testing for targeted therapy selection. The company’s PGxOne™ Plus test covers over 50 genes and helps provide recommendations on over 300 drugs. The LiquidGx™ test has superior limit of detection and a rapid turnaround time. Actionable test results are delivered to physicians in clear, color-coded, and iconographic reports. Providing the relevant information to make more informed treatment decisions.
Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics, and applied chemical markets. With more than 50 years of insight and innovation, Agilent instruments, software, services, solutions, and people provide trusted answers to customers’ most challenging questions. The company generated revenues of $4.47 billion in fiscal 2017 and employs 14,200 people worldwide. Information about Agilent is available at www.agilent.com
Akcea Therapeutics, Inc., an affiliate of Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), is a biopharmaceutical company focused on developing and commercializing drugs to treat patients with serious and rare diseases. Akcea is advancing a mature pipeline of six novel drugs, including TEGSEDITM (inotersen), WAYLIVRATM (volanesorsen), AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx, AKCEA-APOCIII-LRx, and AKCEA-TTR-LRx, all with the potential to treat multiple diseases. All six drugs were discovered by and are being co-developed with Ionis, a leader in antisense therapeutics, and are based on Ionis’ proprietary antisense technology. TEGSEDI is approved in the U.S., E.U. and Canada. WAYLIVRA is under regulatory review for the treatment of familial chylomicronemia syndrome, or FCS, and is currently in Phase 3 clinical development for the treatment of people with familial partial lipodystrophy, or FPL. Akcea is building the infrastructure to commercialize its drugs globally. Akcea is a global company headquartered in Cambridge, Massachusetts. www.akceatx.com
Alexion (NASDAQ: ALXN) is a global biopharmaceutical company focused on serving patients and families affected by rare diseases through the discovery, development and commercialization of life-changing therapies.Since its founding in 1992, Alexion has given hope to people who had none and shined a light on those who felt isolated and alone. But we know that fighting rare diseases takes so much more than hope. It requires persistence, dedication, and a relentless pursuit of the highest levels of medical innovation. At Alexion, our goal is to deliver medical breakthroughs where none currently exist. We are driven because we know people's lives are at stake. Alexion has 2,500 passionate and dedicated employees serving patients in 50 countries around the world. www.alexion.com
Applied Spectral Imaging (ASI) is a global leader in biomedical imaging with a comprehensive product portfolio and a global distribution footprint. The Company's technology, powered by GenASIs, enables Pathology, Cytogenetics and Research laboratories to provide advanced diagnostics to patients. ASI has a wide portfolio of dedicated solutions for Brightfield, Fluorescence and Spectral imaging and analysis, including HiPath Pro, PathFusion, HiBand, HiFISH, Harmony and Rainbow. Founded in 1993, ASI markets, services and supports its products in nearly 50 countries. The Company has worldwide offices in the US and Asia and a global network of distribution partners. www.spectral-imaging.com
APS Medical Billing is a premier billing company that provides expert billing and practice management solutions to practices nationwide. Some of the services provided include expert ICD-10 and CPT coding, contract management, and comprehensive charge capture systems to ensure its client’s financial success. Visit us at: www.apsmedbill.com.
Today's targeted infectious disease diagnostics limit testing to the most common pathogens associated with a clinical syndrome. This leaves infections undiagnosed, may lead to additional downstream testing, patient dissatisfaction and compromised patient care.
Bristol-Myers Squibb is a global biopharmaceutical company focused on discovering, developing and delivering innovative medicines for patients with serious diseases. We are focused on helping patients in disease areas including oncology, cardiovascular, immunoscience and fibrosis. Each day, our employees work together for patients - it drives everything we do.
Change Healthcare is a catalyst for your value-based healthcare system. We are a healthcare technology company that offers software, analytics, network solutions, and technology-enabled services to help create a stronger, more collaborative healthcare system. We help deliver measurable value not only at the point of care, but also before, after, and in between care episodes. www.changehealthcare.com/about
Cleveland Clinic Laboratories is dedicated to providing high-quality, clinically impactful pathology and laboratory diagnostic services combined with readily available consultation from experienced pathologists and laboratory scientists.
Our laboratories offer excellence in coagulation, cytogenetics, flow cytometry, hematopathology, and molecular testing, as well as subspecialty services in anatomic pathology. This approach ensures that every specimen submitted will be evaluated by a pathologist with a high level of diagnostic expertise in that specific field of pathology. For more information, visit clevelandcliniclabs.com.
As the world's largest organization of board-certified pathologists and leading provider of laboratory accreditation and proficiency testing programs, the College of American Pathologists (CAP) serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide. For more information, read the at .
CSI Laboratories is a specialized cancer diagnostics laboratory focused on meeting the unique needs and challenges of pathologists. Independently owned and operated by medical professionals, CSI has offered expert diagnostic testing to pathologists across the U.S. since 1997. Testing offered by CSI includes flow cytometry, cytogenetics, FISH, IHC, and molecular diagnostics. www.csilaboratories.com
The goal of Discern Management Group is to help you maximize revenue and minimize concerns. Discern provides an overall understanding of the business side of your practice. Since Discern is not affiliated with a billing service, our independence allows an unbiased review of your entire practice. Discern will partner with the physician group to maximize income for services already being performed and help stop the trend of decreasing annual revenue. Partnering with Discern gives you the peace of mind that your practice is reaching its maximum potential, allowing you to focus your efforts on patient care and medicine. www.discernmanagementgroup.com
Foundation Medicine is a molecular information company dedicated to a transformation in cancer care, where each patient’s treatment is informed by a deep understanding of the genomic changes that contribute to their disease. Our liquid biopsy, FoundationACT, and our other comprehensive genomic profiles identify molecular alterations and match them to targeted therapies, immunotherapies, and clinical trials. We aim to improve care for patients by serving the needs of clinicians, researchers and biopharma to help advance the science of molecular medicine in cancer. www.foundationmedicine.com
Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious or life-threatening medical conditions. We are among the world's leading biotech companies, with multiple products on the market and a promising development pipeline. www.gene.com/about-us
GenPath, a division of BioReference Laboratories, Inc., is a full service oncology/pathology laboratory with over 15 years of diagnostic experience. GenPath employs specialized pathologists and offers a comprehensive test menu. From routine clinical and special coagulation testing to complex genomic testing for tumor sequencing and hereditary cancer syndromes, the full spectrum of a cancer patient work-up is covered in one laboratory. BioReference Laboratories, Inc. is a wholly owned subsidiary of OPKO Health Inc. www.genpathdiagnostics.com
Since 1981, Healthpac has been a leading national developer of practice management software. The team of experts at Healthpac have made it their mission to deliver the next EVOLUTION of healthcare billing and technology solutions. Our software will shift the focus from data collection to detailed data analytics.
ImagineSoftware is the leading provider of medical billing automation software and revenue cycle management applications. Offering powerful technology solutions for medical billing offices, practices, and hospitals, ImagineSoftware serves more than 46,000 physicians. ImagineSoftware solutions improve financial efficiency, build provider reputation, and ultimately improve the patient payment experience. For more information, visit www.imagineteam.com and follow us on Twitter @ImagineTeam. www.imagineteam.com
Interpace Diagnostics develops molecular diagnostic tests. You can be assured that all of the molecular tests we offer are driven by rigorous, validated science.We power the future of molecular diagnostics, delivering cutting-edge and much-needed mutational analysis that helps risk-stratify for thyroid, pancreatic, and other cancers to better inform treatment decisions. The unique molecular diagnostic tests we offer enable healthcare providers to avoid unnecessary surgeries and better assess the risk of cancer progression in their patients. www.interpacediagnostics.com
The Lawrence D. Share Company and Professional Casualty Corporation can provide the best products at the most competitive rates available in today’s market for Disability Life and Health Insurance, Financial Services and Medical Malpractice. Our clientele includes more than 5000 physicians throughout the United States. www.ldshare.com
Leica Biosystems is a global leader in workflow solutions and automation. As the only company to own the workflow from biopsy to diagnosis, we are uniquely positioned to break down the barriers between each of these steps. Our mission of Advancing Cancer Diagnostics, Improving Lives is at the heart of our corporate culture. Our easy-to-use and consistently reliable offerings help improve workflow efficiency and diagnostic confidence. The company is represented in over 100 countries. It has manufacturing facilities in 9 countries, sales and service organizations in 19 countries, and an international network of dealers. The company is headquartered in Nussloch, Germany. Visit LeicaBiosystems.com for more information.
At Luminex, our mission is is to empower labs to obtain reliable, timely and actionable answers, ultimately advancing health. We serve the needs of our customers in diverse markets including clinical diagnostics, pharmaceutical drug discovery, life science research, immunology, and personalized medicine. Our goal is to transform global healthcare with innovative instruments and assays that deliver cost-effective, rapid results to clinicians and researchers. For further information, please visit www.luminexcorp.com.
For more than 35 years, MagMutual has served as a trusted advisor and strategic ally to thousands of physicians and hospitals. Today we offer the best resources in patient safety, expert defense and comprehensive solutions for professional liability insurance. Our Policy Owners receive exceptional service, financial strength, dividends, rewards and more. www.magmutual.com
As the global reference laboratory for Mayo Clinic, Mayo Medical Laboratories will help you advance patient care, strengthen your practice, and broaden access to specialized testing. www.mayomedicallaboratories.com
MedReceivables Advisor, LLC is a full service outsourcing medical billing company for the hospital based physician. Our company provides complete accounts receivable management services for hospital-based physicians. www.medreceivables.com
For more than a century, Merck has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Today, Merck continues be at the forefront of research to deliver innovative health solutions and advance the prevention and treatment of diseases that threaten people and animals around the world. www.merck.com
Mikroscan's vision is that every patient receives the right diagnosis from the right expert at the right time, regardless of where they live in the world. Mikroscan is committed to partnering with the pathology community by providing technology enabled products and services that increase a pathologist's reach, remove barriers to workload efficiency, and enable new discoveries.
Milestone is a technological innovator of microwave tissue processors, digital imaging systems, and pre-analytical tools for the modern lean laboratory. Our products enable histotechs, pathologists’ assistants, and pathologists to achieve the highest level of productivity, flexibility, and safety. Milestone’s family of rapid microwave processors allow tissue samples to be run in a fraction of the time as compared to conventional methods, providing for same-day diagnosis. MacroPath D, our digital imaging system for grossing areas, allows the user to capture, annotate, and store case photography for diagnostic reports. For more information about our products please visit www.milestonemed.com.
M Labs is a full-service reference laboratory and part of one of largest health care complexes in the world, Michigan Medicine. With 30+ years of reference laboratory experience, MLabs is CLIA-certified/CAP accredited, committing to delivering the highest quality laboratory results to meet the needs of today’s patients in a cost effective and personalized manner. Our nationally recognized faculty comprise one of the strongest groups of diagnostic pathologists in the world. Consultations and second opinions are provided in all subspecialties. MLabs is a recognized leader for advance molecular diagnostic testing, continuously adding new molecular assays. Expertise Delivered Personally. https://mlab.com/
New England Medical Books, an Elsevier Affiliate Medical books and electronic products from Elsevier Medical Publishers
New River Labs is the leading provider of mass spectrometry imaging based tests designed to address clinically challenging problems and enable physicians to improve patient care. Our tests provide actionable intelligence, enabling physicians to develop personalized treatment plans and improve patient outcomes. By targeting clinically challenging problems that are underserved, or unaddressed, by existing tests, we seek to help physicians reduce patient misdiagnosis, mistreatment, and overtreatment. These clinical benefits improve patient care, enhance physician insight, and deliver healthcare savings.
NeoGenomics specializes in cancer genetic testing and information services with the most comprehensive oncology-focused testing menus globally to diagnose and treat cancer. NeoGenomics operates CLIA certified laboratories serving the needs of pathologists, oncologists, academic centers, hospital systems, Pharma, and managed care organizations. Visit http://neogenomics.com/ to learn more about our global locations.
NovoPath, Inc. develops and markets software solutions for the Anatomic Pathology Laboratory market segment that includes local, regional, national, in-house laboratories as well as community and university teaching hospitals and medical centers. Since the release of its flagship product in 1999, NovoPath, Inc. has focused exclusively on Anatomic Pathology. NovoPath's mission is to provide unique and unparalleled solutions and services to all aspects of the Anatomic Pathology sector in a way that improves workflow, reduces the probability of human error, ensures results accuracy for greater patient safety, protects patient confidentiality, and above all, produces more precise and informative diagnostic outcomes. More information is available at www.NovoPath.com.
Paradigm strives to use molecular data to help pathologists and oncologists provide the most effective treatment plan for each patient. Paradigm cancer diagnostic test, PCDx, gives pathologists and oncologists more accurate therapeutic options for patient care. Paradigm works through pathology to get accurate NGS results to the treating physician in less time and using less tissue while involving the pathologists expertise.
Associated Pathologists,d/b/a PathGroup, is the largest physician owned pathology group in the United States. With more than 75 pathologists, we provide a wide range of anatomic, clinical and molecular services to hospitals, multi-speciality groups, surgery centers, physician offices and other clinical reference laboratories, and have done so since 1965. Associated Pathologists is an academic style group practice that has superb range and depth of experience, expertise and certifications in all subspecialty areas of pathology. More information is available about Associated Pathologists/Pathgroup at www.pathgroup.com
PIMS Inc. was incorporated in 1998 and has evolved into a full-service Medical Billing and Practice Management Services company. PIMS provides comprehensive billing and consulting services for providers of all sizes. In addition, PIMS offers an innovative and robust laboratory information system designed specifically for the anatomic pathology practice in mind. Headquartered in our state-of-the-art 23,000 square-foot facility in Tampa, Florida, PIMS is led by a senior management team with many years of diversified medical billing and healthcare revenue cycle management experience. With 100+ highly trained employees, we have you covered. www.pims-inc.com
Sales and Service of Medical, University, State College and Educational Microscopes. SEO specializes in Nikon Microscopes and Imaging products. The service consists of most types and brands.
Founded in 1976, StatLab is a leading developer and manufacturer of cost- effective histology, cytology and immunohistochemistry diagnostic supplies. StatLab offers over 3,000 of the most commonly purchased diagnostic supplies used by independent and hospital-based anatomic pathology laboratories. Over 3,000 anatomic pathology laboratories across the United States rely on StatLab to satisfy their diagnostic supply requirements.
Thermo Fisher Scientific is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. Through the Thermo Scientific brand, we help customers accelerate innovation and enhance productivity. Thermo Fisher Scientific supplies innovative solutions for the world's anatomical pathology industry. With applications that span cancer research and diagnostic processes from specimen collection, processing and staining to advanced imaging and patient tissue sample management.
Founded in 1995, TELCOR is the proven leader of health care software solutions for point of care testing (POCT) and laboratory revenue cycle management (RCM). Customers today need robust, efficient solutions to match laboratory and hospital challenges.https://telcor.com/
University of Florida Health Pathology Laboratories is a pathology services resource for physicians throughout the Southeast United States. We offer a broad range of modern diagnostic and prognostic tests that include applications of advanced technology and the latest research findings. http://pathlabs.ufl.edu/
If your accounts receivable is up, collections are down, and you’re getting excuses from your billing company or personnel, it’s time call Vachette Pathology for an audit. We serve more than 100 clients nationwide and have audited every major pathology billing company, giving us unique insight into optimizing revenue strategy. Vachette is a revenue auditing and practice management firm working with pathology groups, independent labs, hospitals and universities. We also offer guidance for protecting your Medicare revenue while navigating CMS reporting initiatives such as MIPS and PAMA. Want to learn more? Call us at 517-486-4262 or visit online at: www.vachettepathology.com
Wolters Kluwer Health is a global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Major brands include Lippincott Williams & Wilkins (the publisher of JONA, Official Leadership Journal of the Magnet Recognition Program® and Lippincott’s Nursing Solutions) and Ovid, online information search, discovery and management solutions. https://wolterskluwer.com/
The Florida Society of Pathologists (FSP) Poster Review Committee invites the submission of abstracts for display in the FSP Poster Hall at the 2019 FSP Annual Pathology Conference taking place on February 22-24, 2019 at Disney’s Contemporary Resort in Orlando, Florida.
The purpose of the FSP Poster Hall is to stimulate research, provide a venue to share innovative and effective educational programs, showcase unique research projects, and to encourage networking among pathologists.
New this year, all pathologists are invited to submit abstracts for display in the Poster Hall.
Back by popular demand, residents, fellows, and medical students who are enrolled in a full-time approved training program in pathology or sub-specialty of pathology are invited to submit and be eligible to participate in the FSP Poster Competition.
All abstracts must be submitted online, and authors must register and pay for the FSP conference and pay the poster fee. Please read all instructions, information, and policies closely before submitting your poster.
Poster Submission Deadline
Monday, January 28, 2019
5:00 pm EST
Poster Submission Instructions
Please read through the submission instructions below before preparing your poster:
General Information and Policies:
Poster entries can only be accepted electronically and must adhere to the following guidelines:
You will be asked for the following:
The online poster submission does not allow you to save and return to resume later. Therefore, before starting your submission, have all materials and information ready. After the abstract is submitted, you will receive an automated email to confirm your submission. If you do not receive the email within 24 hours, please contact the FSP office at email@example.com or call 904-309-6261.
The poster must relate to an appropriate topic in the field of pathology. Poster authors will be required to indicate which topic BEST matches the content of their abstract. Topics are:
Poster Competition Eligibility
Authors must be a resident, fellow, or medical student enrolled in a full-time approved training program in pathology or sub-specialty of pathology to be eligible to participate in the FSP Poster Competition.
Poster Competition Presentation Process and Awards
Posters submitted for the Poster Competition by residents, fellows and medical students will be pre-judged and selected by FSP judges based on quality, innovation, approach/design, and visuals. Posters will be judged twice and are subject to an additional preliminary review to determine eligibility. If judges deem that changes need to be made for posters to be eligible for presentation, lead authors will be contacted by email. The first judging will be done before the conference, and it will be a blind review. The second judging will be conducted during the poster presentation live at the conference in the FSP Poster Hall. The scores from both judging sessions will be combined to determine the winners. The first-place winner will receive $500, the second-place winner will receive $250, and the third-place winner will receive $150. To be considered for the competition, you must you must be a resident, fellow or medical student and you must submit your poster by the submission deadline.
Onsite judging times will be assigned for residents, fellows and medical students that are participating in the Poster Competition, and authors will be notified of their presentation time. Presentation times will occur on Friday, February 22 and Saturday, February 23 so please make plans to be available on both days. All lead poster authors are required to register for the conference taking place on February 22-24, 2019 at Disney's Contemporary Resort in Orlando to present their poster to judges.*
Winners of the Poster Competition will be announced, and prizes will be awarded on Saturday, February 23.
The FSP will not be responsible for submissions not received via the website or for submission errors caused by Internet service outages, hardware or software delays, power outages, or unforeseen events. Faxed, emailed or mailed hard-copy posters or posters sent on a CD/disc WILL NOT be accepted. If you have questions, please contact the FSP office at firstname.lastname@example.org or call 904-309-6261
*Expenses related to registration, airfare, lodging, and social events/guest fees are the responsibility of the presenter.
The Florida Society of Pathologists (FSP) will hold a fellowship fair and resident roundtable discussion showcasing the various fellowship programs in Florida and the southeast area. The fair will take place on Saturday, February 23, 2018 from 4:00-5:30 pm. This is a unique opportunity to learn about the fellowship programs available to pathology residents and fellows.Participating Fellowship Programs
After meeting with the fellowship programs, FSP will host resident roundtable discussions with FSP board members and prominent pathology thought leaders representing the various fields of pathology practice including clinical, laboratory, hospital based and academic. Residents will spend 10 minutes at each of the five tables to discuss the following topics:
We hope you will join us!
Cocktails and light hors d ‘oeuvres will be served.
FSP Member Login